Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Curative potential of foremost mitogen applications.

Bruce M Wimer1

  • 1JBMW Immunotherapeutics, Albuquerque, NM, USA. Jbmwimer@aol.com

Cancer Biotherapy & Radiopharmaceuticals
|February 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitogen information summaries.

Cancer biotherapy & radiopharmaceuticals·2002
Same author

Mitogens for curative therapy of HIV-1 infections; an update.

Cancer biotherapy & radiopharmaceuticals·2002
Same author

Mitogen therapy for biological warfare/terrorist attacks and viral hemorrhagic fever control.

Cancer biotherapy & radiopharmaceuticals·2002
See all related articles

Mitogen therapy offers a promising approach to cancer treatment by selectively destroying malignant cells while stimulating the immune system. This therapy also aids in recovery from various medical treatments and infections.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Mitogen therapy is explored as a novel treatment for malignant tumors.
  • Existing treatments often have significant side effects and limited efficacy.

Purpose of the Study:

  • To summarize the critical attributes of mitogen therapy for managing malignant tumors.
  • To outline the potential role of L4 immunotherapy for various infections.

Main Methods:

  • Review of in vitro data from lectin-dependent cellular cytotoxicity (LDCC) systems.
  • Analysis of mitogen properties including PHA-L4, Fraction IV PHA, and PWM.
  • Discussion of potential administration routes for infection treatment.

Main Results:

Related Experiment Videos

  • Mitogens demonstrate selective destruction of mutated tissues without harming normal cells.
  • Mitogens induce global immunostimulation, activating immune cells and cytokine production.
  • Mitogen therapy aids recovery from immunosuppressive effects of tumors and treatments.

    • Conclusions:

    • Mitogen therapy, particularly PHA-L4, shows potential for treating malignancies and infections.
    • The therapy reconstitutes immune competence, vital for lasting cures.
    • Various administration routes and mitogen types offer versatile treatment options.